Sangrix Inc. (SGRX) Cash Flow Statement
Where SGRX’s cash came from and went, FY2026
June 30, 2026 · U.S. dollars- Cash from operations
- −$2.9M
- Capital expenditures
- $0
- Free cash flow
- −$2.9M
- Returned to shareholders
- —
- Change in cash
- $1.5M cash at year-end $1.6M
Cash from operations
−$2.9M
Net borrowing (repayment)
+$6.4M
Other financing
−$1.8M
Currency & other
−$200,000
Change in cash
$1.5M
Drawn to scale: where the cash came from and how it was used. Hover for values.
SGRX operating cash flow, capex and free cash flow
Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)
SGRX cash flow trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$2.5MFY2017 | −$2.9MFY2026 | — | |
| Capital expenditures | $11,671FY2017 | $0FY2026 | −100.0% | |
| Free cash flow | −$2.5MFY2017 | −$2.9MFY2026 | — | |
| Free cash flow margin | −4.0%FY2017 | −5,799.7%FY2025 | −5,795.8 pts | |
| Operating cash flow / net income | −1.02FY2017 | −1.05FY2019 | −0.02 | |
| Stock-based compensation | $1.9MFY2021 | $0FY2026 | −100.0% | |
| Dividends paid | $0FY2022 | $0FY2026 | — | |
| Capex / revenue | 0.0%FY2017 | 0.0%FY2025 | 0.0 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SGRX cash flow by activity
OperatingInvestingFinancingChange in cash
SGRX net income vs operating cash flow
Net incomeOperating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
SGRX cash flow statement
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | −$14.3M | −$6.5M | −$18.3M | −$28.2M | −$5.3M | −$3.6M | −$3.8M | $5.0M | $3.8M | $2.5M |
| Depreciation & amortization | $0 | — | $900,938 | $5.4M | $276,763 | — | $1,579 | $521,925 | $542,189 | $531,625 |
| Stock-based compensation | $0 | — | $73,230 | $67,271 | $1.6M | $1.9M | — | — | — | — |
| Change in working capital | −$236,978 | $528,636 | −$4.2M | −$4.6M | −$20.2M | $193,468 | −$4.8M | −$11.6M | −$10.2M | −$5.6M |
| Other non-cash items | $11.6M | $3.7M | $13.6M | $20.7M | $9.4M | −$8.8M | $2.8M | $768,643 | $2.3M | $131,488 |
| Cash from operating activities | −$2.9M | −$2.3M | −$7.9M | −$6.8M | −$14.2M | −$10.4M | −$5.9M | −$5.3M | −$3.6M | −$2.5M |
| Investing activities | ||||||||||
| Capital expenditures | $0 | −$3 | −$4 | −$115,033 | −$8.3M | $0 | $0 | −$20,639 | −$89,349 | −$11,671 |
| Investments (net) | — | — | −$3.6M | $0 | −$3.0M | — | — | — | — | — |
| Acquisitions & other investing | — | $1.5M | $4.7M | $4.4M | −$3,177 | — | $159,062 | $1.2M | −$2 | −$3 |
| Cash from investing activities | — | $1.5M | $1.0M | $4.3M | −$11.3M | — | $159,062 | $1.2M | −$89,351 | −$11,674 |
| Financing activities | ||||||||||
| Dividends paid | $0 | — | $0 | $0 | $0 | — | — | — | — | — |
| Net borrowing (repayment) | $6.4M | — | $3.7M | $2.4M | $0 | — | — | — | — | — |
| Shares issued | $0 | $0 | $4.0M | $0 | $35.0M | $0 | $0 | $0 | $0 | $0 |
| Other financing | −$1.8M | −$608,712 | $556,218 | $127,527 | −$9.1M | $8.5M | $4.1M | $6.7M | $4.0M | $2.5M |
| Cash from financing activities | $4.6M | −$608,712 | $8.3M | $2.5M | $25.9M | $8.5M | $4.1M | $6.7M | $4.0M | $2.5M |
| Summary | ||||||||||
| Net change in cash | $1.5M | −$1.4M | $1.4M | −$1,531 | $387,979 | −$1.4M | −$2.1M | $2.9M | $297,563 | −$30,318 |
| Cash at end of period | $1.6M | $55,639 | $1.4M | $16,274 | $493,910 | $105,931 | $1.1M | $3.2M | $319,093 | $21,530 |
| Free cash flow | −$2.9M | −$2.3M | −$7.9M | −$6.9M | −$22.5M | −$10.4M | −$5.9M | −$5.3M | −$3.7M | −$2.5M |
| Free cash flow margin | — | −5,799.7% | −274.5% | −109.8% | −11,717.2% | — | −24.4% | −5.3% | −3.6% | −4.0% |
| Capex / revenue | — | 0.0% | 0.0% | 1.8% | 4,316.5% | — | 0.0% | 0.0% | 0.1% | 0.0% |
| Operating cash flow / net income | — | — | — | — | — | — | — | −1.05 | −0.95 | −1.02 |
| Mar '26 | Dec '25 | Sep '25 | Sep '24 | Dec '23 | Sep '23 | Dec '22 | Dec '21 | Dec '20 | Mar '20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | −$18.4M | −$18.4M | −$3.7M | −$10.5M | −$7.1M | −$24.2M | −$4.0M | $3.5M | −$1.6M | −$77,601 |
| Depreciation & amortization | — | — | — | — | $900,938 | $3.0M | $2.4M | — | $3,280 | $320,786 |
| Change in working capital | −$571,289 | −$571,289 | $1.1M | −$459,801 | −$3.7M | $2.9M | −$1.8M | −$5,947 | −$2.6M | −$4.8M |
| Other non-cash items | $16.9M | $16.9M | $3.2M | $7.6M | $5.3M | $14.7M | $203,628 | −$3.4M | −$6.9M | $1.8M |
| Cash from operating activities | −$2.1M | −$2.1M | $634,595 | −$3.3M | −$4.6M | −$3.6M | −$3.2M | $71,290 | −$11.1M | −$2.7M |
| Investing activities | ||||||||||
| Capital expenditures | −$2.1M | −$2.1M | −$5 | −$1 | −$4 | −$115,038 | −$4 | −$7.0M | −$2 | −$410,441 |
| Acquisitions & other investing | $1.2M | $1.2M | — | −$2.7M | $3.7M | $4.1M | $288,254 | −$3,164 | — | $175,419 |
| Cash from investing activities | −$845,600 | −$845,600 | — | −$2.7M | $3.7M | $4.0M | $288,250 | −$7.0M | — | −$235,022 |
| Financing activities | ||||||||||
| Shares issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other financing | $3.4M | $3.4M | −$608,712 | $525,502 | $7.8M | −$402,189 | $2.9M | $14.2M | $9.5M | $2.0M |
| Cash from financing activities | $3.4M | $3.4M | −$608,712 | $525,502 | $7.8M | −$402,189 | $2.9M | $14.2M | $9.5M | $2.0M |
| Summary | ||||||||||
| Net change in cash | $429,331 | $429,331 | $25,883 | −$5.5M | $6.9M | −$16,613 | −$7.3M | $7.2M | −$2.1M | $2.3M |
| Cash at end of period | $484,970 | $484,970 | $55,639 | $1.4M | $6.9M | $16,274 | $32,887 | $7.4M | $160,211 | $2.3M |
| Free cash flow | −$4.2M | −$4.2M | $634,600 | −$3.3M | −$4.6M | −$3.7M | −$3.2M | −$6.9M | −$11.1M | −$3.1M |
| Free cash flow margin | — | — | 1,606.8% | — | −160.0% | −88.3% | −153.6% | — | −17.7% | −6.2% |
| Capex / revenue | — | — | 0.0% | — | 0.0% | 2.7% | 0.0% | — | 0.0% | 0.8% |
| Operating cash flow / net income | — | — | — | — | — | — | — | 0.02 | — | — |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
SGRX cash generation
In fiscal 2026 (ended June 30, 2026), Sangrix generated -$2.9 million of cash from operations and spent $0 on capital expenditures, leaving free cash flow of -$2.9 million. Cash and equivalents rose by $1.5 million over the year.
Related: SGRX income statement, SGRX balance sheet. See the SGRX stock overview for the latest quote and news.
SGRX cash flow FAQ
What is Sangrix's free cash flow?
Sangrix's free cash flow was -$2.9 million in fiscal 2026: -$2.9 million of operating cash flow minus $0 of capital expenditures It was -$2.3 million a year earlier..
How much cash does Sangrix generate from operations?
Sangrix generated -$2.9 million of cash from operating activities in fiscal 2026.